nitroglycerin has been researched along with quinapril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| deCampora, P; DeLuca, N; Enea, I; Lembo, G; Mele, AF; Rendina, V; Romano, M; Rubattu, S; Tritto, C; Volpe, M | 1 |
| Haber, HE; Mancini, GB; O'Neill, B; Pepine, CJ; Pitt, B; Schlaifer, JD; Wargovich, TJ | 1 |
| Haber, HE; Mancini, GB; O'Neill, BJ; Pepine, CJ; Pitt, B; Schlaifer, JD | 1 |
| Feldman, RD; Schmidt, ND | 1 |
1 review(s) available for nitroglycerin and quinapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for nitroglycerin and quinapril
| Article | Year |
|---|---|
Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Topics: Acetylcholine; Adenosine; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Female; Humans; Isoquinolines; Male; Microcirculation; Middle Aged; Nitroglycerin; Pilot Projects; Quinapril; Tetrahydroisoquinolines; Vasodilator Agents | 1997 |
Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Coronary Vessels; Double-Blind Method; Endothelium, Vascular; Humans; Isoquinolines; Middle Aged; Nitroglycerin; Quinapril; Retrospective Studies; Smoking; Tetrahydroisoquinolines; Vasodilator Agents; Vasomotor System | 1999 |
Quinapril treatment enhances vascular sensitivity to insulin.
Topics: Adrenergic beta-Agonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Double-Blind Method; Drug Administration Routes; Drug Therapy, Combination; Humans; Hypertension; Hypoglycemic Agents; Insulin; Isoproterenol; Isoquinolines; Middle Aged; Nitroglycerin; Phenylephrine; Quinapril; Sodium; Sodium, Dietary; Tetrahydroisoquinolines; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
3 other study(ies) available for nitroglycerin and quinapril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Blood Volume; Cardiac Output, Low; Cardiomyopathy, Dilated; Female; Heart; Hormones; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Nitroglycerin; Plasma Substitutes; Quinapril; Tetrahydroisoquinolines | 1992 |